Brief: Carlyle Group May Sell Up To 10% Stake In India's Piramal Pharma Via Block Deals, Moneycontrol reports
03/07/2025 13:33
July 3 (Reuters) - Carlyle Group Inc CG.O: CARLYLE GROUP MAY SELL UP TO 10% STAKE IN INDIA'S PIRAMAL PHARMA VIA BLOCK DEALS - MONEYCONTROL Source text: [ID:] Further company coverage: CG.O ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington